VANDA PHARMACEUTICALS INC. (VNDA)

Import this data to Google Sheets with:

=jivedata("VNDA","financials")

Full statements spill as a table. For one cell: =jivedata("VNDA","Revenue") or =jivedata("VNDA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

VANDA PHARMACEUTICALS INC.

VNDA • CIK 0001347178

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$192,640	$198,772	$216,105	$215,721
Operating Income (Loss)	$-13,952	$-40,660	$-151,168	$-185,670
Other Income	$20,291	$17,739	$12,521	$8,470
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$6,339	$-22,921	$-138,647	$-177,200
Income Tax Expense (Benefit)	$3,830	$-4,021	$81,827	$97,653
Net Income (Loss) Attributable to Parent	$2,509	$-18,900	$-220,474	$-274,853
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization	$14,796	$11,314	$13,044	$13,506
Research and Development Expense	$76,823	$74,431	$109,271	$116,957
Selling, General and Administrative Expense	$112,883	$146,414	$237,951	$263,450
Amortization of Intangible Assets	$2,090	$7,273	$7,007	$7,478
Costs and Expenses	$206,592	$239,432	$367,273	$401,391
Weighted Average Number of Shares Outstanding, Basic	57,380,975	58,149,087	58,930,157	60,013,190
Weighted Average Number of Shares Outstanding, Diluted	57,557,911	58,149,087	58,930,157	60,013,190
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	6,464,057	6,493,140	6,078,795	5,490,893
Weighted Average Number Diluted Shares Outstanding Adjustment	176,936	0	0	0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$135,821	$102,316	$84,851	$55,882
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	$252,443	$272,327	$178,996	$114,147
Property, Plant and Equipment, Net	$2,037	$2,132	$2,248	$2,578
Accounts Receivable, after Allowance for Credit Loss, Current	$34,155	$47,101	$54,578	$59,692
Operating Lease, Right-of-Use Asset	$7,103	$5,602	$3,923	$14,598
Inventory, Net	$1,357	$1,726	$1,852	$1,678
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	—	$4,943	$7,343	$6,772
Prepaid Expense and Other Assets, Current	$9,170	$15,420	$26,985	$33,085
Finite-Lived Intangible Assets, Net	$121,369	$114,096	$117,089	$113,115
Assets, Current	$432,946	$438,890	$347,262	$264,484
Deferred Income Tax Assets, Net	$75,000	$81,440	$0	$0
Assets	$648,440	$656,204	$488,948	$412,467
Operating Lease, Liability, Noncurrent	$7,006	$4,944	$2,991	$15,027
Finance Lease, Liability, Noncurrent	—	$3,146	$4,076	$3,175
Other Liabilities, Noncurrent	$8,827	$9,587	$9,533	$10,054
Liabilities	$103,530	$117,658	$161,762	$192,282
Accounts Payable and Accrued Liabilities, Current	$38,460	$39,086	$68,297	$69,994
Liabilities, Current	$87,697	$99,981	$145,162	$164,026
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$58	$58	$59	$60
Additional Paid in Capital, Common Stock	$700,274	$712,706	$721,264	$725,933
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-30	$74	$629	$38
Retained Earnings (Accumulated Deficit)	$-155,392	$-174,292	$-394,766	$-505,846
Stockholders' Equity Attributable to Parent	$544,910	$538,546	$327,186	$220,185
Preferred Stock, Shares Authorized	20,000,000	20,000,000	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	150,000,000	150,000,000	150,000,000	150,000,000
Common Stock, Shares, Issued	57,534,499	58,310,644	59,101,630	60,454,687

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$2,509	$-18,900	$-220,474	$-274,853
Net Cash Provided by (Used in) Operating Activities	$12,801	$-15,757	$-109,442	$-142,331
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$47	$-163	$23	$-253
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$792	$-33,505	$-17,465	$-25,101
Depreciation	$920	$859	$1,103	$1,145
Share-based Payment Arrangement, Noncash Expense	$14,040	$12,432	$9,474	$9,067
Payments to Acquire Property, Plant, and Equipment	$383	$490	$998	$674
Investment Income, Net, Amortization of Discount and Premium	$8,799	$6,994	$2,053	$927
Payments to Acquire Debt Securities, Available-for-sale	$512,606	$364,773	$112,379	$16,079
Debt Securities, Available-for-sale, Realized Gain (Loss)	$-655	$0	$0	$0
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$601,598	$352,062	$208,237	$147,025
Amortization of Intangible Assets	$2,090	$7,273	$7,007	$7,478
Net Cash Provided by (Used in) Investing Activities	$-12,056	$-17,430	$94,860	$120,272
Deferred Income Tax Expense (Benefit)	$-1,286	$-6,482	$81,443	$97,212
Other Noncash Income (Expense)	$-3,419	$-2,613	$-1,943	$174
Finance Lease, Principal Payments	—	$155	$1,991	$2,789
Payment, Tax Withholding, Share-based Payment Arrangement	—	—	$915	$0
Net Cash Provided by (Used in) Financing Activities	$0	$-155	$-2,906	$-2,789
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$136,290	$102,785	$85,320	$27,558
Increase (Decrease) in Accounts Receivable	$707	$13,012	$7,463	$14,779
Increase (Decrease) in Prepaid Expense and Other Assets	$-8,523	$6,816	$12,067	$11,894
Increase (Decrease) in Inventories	$771	$29	$3,466	$1,051
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$-10,984	$1,708	$15,820	$10,538

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("VNDA","financials")

Full statements spill as a table. For one cell: =jivedata("VNDA","Revenue") or =jivedata("VNDA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.